|[April 30, 2012]
GenomeQuest and Questel Partner on IP Platform Integration
DENVER --(Business Wire)--
PIUG 2012 Annual Conference - Questel,
a leader in online information services for over 40 years, and GenomeQuest,
a global provider of large-scale genomic software applications,
announced today a partnership to integrate the two companies' platforms
for researching and managing global IP. Specifically, GQ-IP users will
now have the option to review biological sequence patents directly on
Questel's Orbit platform.
GQ-IP is the world's only complete, integrated research platform for
global IP on biological sequences. It offers researchers the tools
needed to complete assignments in sequence patentability, freedom to
operate, potential infringement, competitive intelligence and business
opportunity. Known for one of the largest IP databases collections in
the world, Orbit offers a wide array of tools for searching, mapping,
watching, archiving and sharing information, as well as analyzing and
managing IP portfolios.
"We have invested heavily in content quality and coverage," said Questel
CEO Charles Besson. "Our translations, concept extraction, assignee
normalization and abstract enhancements are being continuously
reprocessed and optimized to improve the speed and precision of search
results. GenomeQuest users wll love this new universe."
The integration makes it easy for researchers to take advantage of
GenomeQuest's unique collection and dedicated biological sequence search
engine as well as Questel's unmatched coverage of value-added patent
databases, semantic search and advanced patent landscaping tools.
"GenomeQuest has built up GQ-IP's ease of use and depth of content to
allow users to complete more research and more reporting in less time,"
said Richard Resnick, CEO of GenomeQuest. "Our partnership with Questel
further extends our interactive research environment and expands the
high level of productivity that GQ-IP provides to customers. We look
forward to collaborating with Questel on additional integration
opportunities in the coming months."
Questel and GenomeQuest are welcoming their partner customers with a
free trial period. More information on this offer, including upcoming
educational webinars, is available at Welcome
Questel and Welcome
Questel has been focusing on its core business, Intellectual Property
since its inception in the early 70's. We provide a suite of
leading-edge patent, trademark and industrial design services to
researchers, lawyers, scientists, and competitive intelligence
professionals. Questel built Fampat, the largest databases collections
in the world and available in our portal Orbit.com for searching,
mapping, watching, archiving and sharing information, as well as
analyzing and managing IP portfolios. Since 2007, Questel has been
supported by the leading European mid-cap Private Equity investor,
Syntegra Capital. For more information, please visit www.questel.com.
GenomeQuest is a global provider and consistent pioneer in large-scale
genomic software applications. Based on a whole/multi-genome engine and
hosting platform, the company's products now include GQ-IP for global
research and management of intellectual property on genomic sequences,
GQ-Dx for decision-support and research in molecular diagnostics, and
GQ-Ag for agricultural research. GenomeQuest serves major pharmaceutical
companies, global agriculture firms, biotech firms, IP legal teams,
genome centers, academic research centers, diagnostic labs, and
universities around the world. Learn more at www.genomequest.com.
[ Back To TMCnet.com's Homepage ]